Stay updated with breaking news from Oche. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Intech Investment Management LLC trimmed its position in shares of Chemed Co. (NYSE:CHE – Get Rating) by 11.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 3,131 shares of the company’s stock after selling 419 shares during the quarter. Intech Investment Management LLC’s holdings in Chemed […]
Cim LLC cut its holdings in Chemed Co. (NYSE:CHE – Get Rating) by 4.7% in the fourth quarter, Holdings Channel reports. The fund owned 2,309 shares of the company’s stock after selling 115 shares during the quarter. Cim LLC’s holdings in Chemed were worth $1,139,000 as of its most recent SEC filing. A number of […]
CUET UG 2023 Day 1 Exam: Unlike last year, the first shift of the nationwide CUET went smoothly without any major accidents, as students who came out after the exam called the paper
StockNews.com started coverage on shares of Chemed (NYSE:CHE – Get Rating) in a research report report published on Thursday morning. The firm issued a buy rating on the stock. Several other brokerages also recently weighed in on CHE. Oppenheimer boosted their price objective on Chemed from $580.00 to $610.00 in a research report on Friday, […]
Fenebrutinib is an investigational, potent and highly selective oral Bruton's tyrosine kinase (BTK) inhibitor, the only reversible BTK inhibitor currently in Phase III multiple sclerosis (MS) trialsPhase